Roche has said it will continue with talks with UK health officials to bring its multiple sclerosis drug Ocrevus to NHS patients with primary progressive disease, after NICE said it was not
Google Ventures and US healthcare specialist Redmile were among a group of investors supporting a £35.5 million funding round for UK biotech Evox Therapeutics, which specialises in drugs de
Roche has revealed new trial data that make the case for use of its haemophilia A drug Hemlibra in an expanded patient group, ahead of a decision by the FDA in the autumn.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.